4//SEC Filing
Kelly John Alexander 4
Accession 0001628280-25-034531
CIK 0001357874other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:30 PM ET
Size
5.4 KB
Accession
0001628280-25-034531
Insider Transaction Report
Form 4
Kelly John Alexander
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-03$4.26/sh−14,827$63,163→ 73,485 total
Footnotes (2)
- [F1]The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the settlement of 44,368 RSUs which vested on January 20, 2025. The settlement occurred on July 3, 2025, as approved by the Issuer's Compensation Committee. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F2]Includes 2,056 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $7.21.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001590030
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:30 PM ET
- Size
- 5.4 KB